3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Dermatologic
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Breast
1
Conditions
Lymphoma, Follicular
3
Lymphoma
3
Lymphoma, Non-Hodgkin
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Epstein-Barr Virus Infections
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
X-Rays
5
Phantoms, Imaging
5
Filgrastim
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Gemcitabine
4
Biopsy
4
tazemetostat
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Etoposide
3
Drug Therapy
3
Carboplatin
3
Busulfan
3
Bevacizumab
3
ulixertinib
2
tipifarnib
2
spartalizumab
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ganitumab
2
ensartinib
2
aflibercept
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Interferons
×
Lymphoid
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled